Real-world clinical impact of selumetinib in adult patients with neurofibromatosis type 1 and plexiform neurofibromas: Preliminary results of the SCAN study

Koselugo (selumetinib) - AstraZeneca

Jessica Schulte; Theresa Dettling; Alyssa Bowling; Genevieve Lyons; Lynn Huynh; Tracy Guo; Qing Liu; Mina Lobbous

Sep 9, 2026